Bioniz
Latest round
- Series A
Last raised
- Dec 2015
Total raised
- $16M
Investors
- 2
About Bioniz
Bioniz, LLC, founded in 2010 and headquartered in Irvine, US, focuses on therapeutic solutions for autoimmune diseases and inflammation.550 mn. The company was acquired by Equillium, Inc. in February 2022, further enhancing its pipeline of immunomodulatory drug candidates.Bioniz focuses on developing innovative therapeutic solutions leveraging its proprietary technology platform. Its core offerings include advanced biopharmaceutical solutions targeting significant unmet medical needs in autoimmune diseases, inflammation, and chronic conditions.Bioniz operates a revenue model based on direct sales to healthcare providers and partnerships with pharmaceutical wholesalers. Their transaction structure revolves around product sales, with potential subscription-based models for ongoing therapies.Following the acquisition by Equillium, Inc. in February 2022, Bioniz aims to expand its portfolio with new immunomodulatory drug candidates. Specific geographic targets are currently being identified as they strategize their approach to market expansion.
Who invested in Bioniz
2 investors across 1 round
See all investors in Bioniz
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 17, 2015
Amount
$16M
Investors
Questions about Bioniz
Who invested in Bioniz?
Bioniz has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bioniz raised?
Bioniz has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bioniz last raise money?
Bioniz's most recent round on record is a Series A, in Dec 2015.
What does Bioniz do?
Bioniz, LLC, founded in 2010 and headquartered in Irvine, US, focuses on therapeutic solutions for autoimmune diseases and inflammation.
Where is Bioniz headquartered?
Bioniz is headquartered in Irvine, US.
Which VCs invest in companies like Bioniz?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bioniz's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bioniz? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.